Sectoral Asset Management’s Pacira BioSciences PCRX Stock Holding History

Sectoral Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,300	Closed	-$331K	–	158
2020 Q2	$331K	Buy	+6,300	New	+$263K	0.03%	154
2015 Q4	–	Sell	-18,357	Closed	-$754K	–	78
2015 Q3	$754K	Buy	18,357 +725	+4%	+$44.4K	0.03%	71
2015 Q2	$1.25M	Buy	17,632 +3,693	+26%	+$291K	0.05%	68
2015 Q1	$1.24M	Buy	+13,939	New	+$1.41M	0.05%	70

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Sectoral Asset Management's PCRX Position: Q3 2020 in Review

Sectoral Asset Management sold out of Pacira BioSciences (PCRX) in Q3 2020, closing a stake of 6,300 shares — an estimated $331K sold.

Sectoral Asset Management first reported a position in PCRX in Q1 2015 and held it in 4 quarters. The position peaked at $1.25M in Q2 2015. 257 funds tracked by Wall St. Rank hold PCRX as of Q3 2020.

Sectoral Asset Management reported no remaining Pacira BioSciences position as of Q3 2020 after selling out during the quarter.
Sectoral Asset Management sold 6,300 Pacira BioSciences shares in Q3 2020, an estimated $331K.
Sectoral Asset Management first reported a position in Pacira BioSciences in Q1 2015 and held it in 4 quarters.
Sectoral Asset Management's Pacira BioSciences position peaked at $1.25M in Q2 2015.
257 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2020.

Based on Sectoral Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.